BioSpace News Archive

Exicure, Inc. (NASDAQ: XCUR), the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) technology, announced that it will host a virtual R&D Day on Thursday, January 7th, 2021 from 09:00 am to 10:30 am ET to discuss Exicure’s neuroscience pipeline, including its lead program for Friedreich’s Ataxia which has progressed into IND-enabling studies.

C-RAD announces today that C-RAD has been selected as the partner to implement surface tracking technology for three proton cancer treatment centers in the US.

emids, a leader in digital engineering and transformation solutions to the healthcare industry, today announced the appointment of Sriraman Nagarajan as President of its Life Sciences business unit.

Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase”), a clinical-stage pharmaceutical company developing therapeutics for Parkinson’s disease and related disorders that arise inside and outside of the brain, announced today the closing of its initial public offering of 1,800,000 shares of common stock at a public offering price of $10.00 per share.

Eurofins Genomics (Paris:ERF) launches an optimised, cost-effective, SARS-CoV-2, next-generation sequencing service providing full length viral genome sequences. The best-in-class ARTIC NGS Oligo mix synthesized by Eurofins Genomics’ Synthesis branch will be commercially available shortly

KEY CAPITAL CORPORATION advises that the Company, through Key Biotec, is offering an unique opportunity to major investors, institutions, and/or government agencies to partner a patent protected oral pill COVID-19 therapeutic vaccine that has been developed by the Immunitor scientific team, and subject to clinical validation and regulatory approvals, is market ready and able to support an urgent global need.

Sunstar Americas, Inc. is voluntarily recalling Paroex® Chlorhexidine Gluconate Oral Rinse USP, 0.12% products bearing an expiration date from 12/31/2020 – 9/30/2022 to the consumer level.

VNM USA, in partnership with PrecisionOS™, foresees the next decade of surgical education being driven largely by immersive virtual reality training modules.

GenMark Diagnostics, Inc., a leading provider of automated, multiplex molecular diagnostic testing systems, announced that the company plans to participate in two upcoming investor conferences.

DermTech, Inc. (NASDAQ:DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today that DermTech management will present at the ICR Conference 2021 on Thursday, January 14, 2021 at 10:00 a.m. Eastern time. Interested parties may access a live webcast of the presentation and, for 90 days following the ICR Conference 2021, an archived webcast of the presenta